IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.
Clinical trial NCT04933799 · UNKNOWN
Trial details
- NCT number
- NCT04933799
- Sponsor
- Giovanni Franchin, M.D, Ph.D
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-06
- Primary completion
- 2022-03-06
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.